home / stock / jnce / jnce quote
Last: | $1.88 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $1.88 |
High: | $0 |
Low: | $0 |
Volume: | 169,314 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.88 | $0 | $1.88 | $0 | $0 | 169,314 | 05-04-2023 |
$1.88 | $1.92 | $1.88 | $1.93 | $1.88 | 11,600,631 | 05-03-2023 |
$1.93 | $1.91 | $1.93 | $1.93 | $1.91 | 2,334,721 | 05-02-2023 |
$1.92 | $1.93 | $1.92 | $1.9404 | $1.905 | 1,911,932 | 05-01-2023 |
$1.93 | $1.93 | $1.93 | $1.95 | $1.92 | 635,051 | 04-28-2023 |
$1.935 | $1.93 | $1.935 | $1.95 | $1.91 | 802,831 | 04-27-2023 |
$1.93 | $1.94 | $1.93 | $1.9509 | $1.91 | 1,105,970 | 04-26-2023 |
$1.93 | $1.93 | $1.93 | $1.96 | $1.9273 | 874,915 | 04-25-2023 |
$1.9 | $1.91 | $1.9 | $1.92 | $1.9 | 284,462 | 04-24-2023 |
$1.91 | $1.9 | $1.91 | $1.92 | $1.9 | 590,360 | 04-21-2023 |
$1.91 | $1.9 | $1.91 | $1.915 | $1.895 | 447,693 | 04-20-2023 |
$1.9 | $1.91 | $1.9 | $1.92 | $1.9 | 810,870 | 04-19-2023 |
$1.9 | $1.92 | $1.9 | $1.935 | $1.9 | 567,897 | 04-18-2023 |
$1.92 | $1.9 | $1.92 | $1.98 | $1.9 | 982,318 | 04-17-2023 |
$1.92 | $1.93 | $1.92 | $1.93 | $1.89 | 830,212 | 04-14-2023 |
$1.92 | $1.87 | $1.92 | $1.94 | $1.87 | 784,168 | 04-13-2023 |
$1.89 | $1.87 | $1.89 | $1.9 | $1.86 | 1,627,018 | 04-12-2023 |
$1.87 | $1.87 | $1.87 | $1.89 | $1.86 | 629,684 | 04-11-2023 |
$1.87 | $1.87 | $1.87 | $1.88 | $1.86 | 1,115,576 | 04-10-2023 |
$1.89 | $1.88 | $1.89 | $1.9 | $1.86 | 716,586 | 04-07-2023 |
News, Short Squeeze, Breakout and More Instantly...
Jounce Therapeutics Inc. Company Name:
JNCE Stock Symbol:
NASDAQ Market:
Jounce Therapeutics Inc. Website:
CAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE) (“Jounce” or the “Company”), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Co...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., April 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. ("Jounce" or t...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE)...